These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15688674)
1. Malignant mixed mullerian sarcomas of the uterus--the LSUHSC Shreveport experience. Ivy JJ; Unger JB J La State Med Soc; 2004; 156(6):324-6. PubMed ID: 15688674 [TBL] [Abstract][Full Text] [Related]
2. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683 [TBL] [Abstract][Full Text] [Related]
3. Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus. Manolitsas TP; Wain GV; Williams KE; Freidlander M; Hacker NF Cancer; 2001 Apr; 91(8):1437-43. PubMed ID: 11301390 [TBL] [Abstract][Full Text] [Related]
4. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma. Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343 [TBL] [Abstract][Full Text] [Related]
5. Prognostic features of surgical stage I uterine carcinosarcoma. Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221 [TBL] [Abstract][Full Text] [Related]
6. Malignant mixed Mullerian tumours of the uterus--a ten-year experience. Ho SP; Ho TH Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422 [TBL] [Abstract][Full Text] [Related]
7. Prognostic features of sarcomas and mixed tumors of the endometrium. Peters WA; Kumar NB; Fleming WP; Morley GW Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081 [TBL] [Abstract][Full Text] [Related]
8. Malignant mixed mullerian tumours of the body of the uterus: a clinicopathological study of 20 cases. Muthuphei MN; Maluleke HJ Cent Afr J Med; 1998 Feb; 44(2):45-7. PubMed ID: 9675973 [TBL] [Abstract][Full Text] [Related]
9. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Dusenbery KE; Potish RA; Judson P Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141 [TBL] [Abstract][Full Text] [Related]
10. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852 [TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of 105 cases with uterine sarcoma. Yoney A; Eren B; Eskici S; Salman A; Unsal M Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406 [TBL] [Abstract][Full Text] [Related]
17. Malignant mixed müllerian tumors of the ovary. Wei CF; Hwang SH; Ho CM; Shih BY; Chien TY Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):344-8. PubMed ID: 10820916 [TBL] [Abstract][Full Text] [Related]
18. Morphologic prognostic factors of malignant mixed müllerian tumor of the uterus: a clinicopathologic study of 58 cases. Gagné E; Têtu B; Blondeau L; Raymond PE; Blais R Mod Pathol; 1989 Sep; 2(5):433-8. PubMed ID: 2554278 [TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic factors in malignant parotid gland tumors. Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796 [TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological analysis on 106 cases with uterine sarcoma]. Liao Q; Wang J; Han J Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]